Is the use of two versus one long-acting bronchodilator by patients with COPD associated with a higher risk of acute coronary syndrome in real-world clinical practice?
Crossref DOI link: https://doi.org/10.1136/bmjresp-2020-000840
Published Online: 2021-01-25
Published Print: 2021-01
Update policy: https://doi.org/10.1136/crossmarkpolicy
Parkin, Lianne https://orcid.org/0000-0002-6824-6176
Williams, Sheila
Barson, David
Sharples, Katrina
Horsburgh, Simon
Jackson, Rod
Dummer, Jack https://orcid.org/0000-0003-1581-6857
License valid from 2021-01-24